Furthermore, we have recently reported that 2HF binds directly to Rlip, inhibiting its transport activity and potentiating the anticancer activity of anti-Rlip antibodies in lung cancer, indicating that Rlip inhibition is a mechanism of action of 2HF [14]. Here, RALBP1 is linked to lung carcinoma.